The Europe Hysterectomy Device Market would witness market growth of 4.9% CAGR during the forecast period (2022-2028).
Surgery may be the only option if the patient's uterus is the source of constant pelvic pain. However, some types of pelvic pain are not resolved by a hysterectomy. In addition, a hysterectomy that is not necessary could lead to additional issues. Some people elect hysterectomies, which remove the uterus and cervix, to match their bodies with their gender identities better. Removing the ovaries and fallopian tubes is another possibility with this kind of surgery. Patients are no longer able to become pregnant after a hysterectomy.
So, It is advised to ask the doctor about alternate treatment options if the patient wishes to get pregnant in the future. A hysterectomy can be the only option if the patient has cancer. Yet, there might be alternative therapies for problems such as uterine prolapse, endometriosis, and fibroids. Removing both ovaries results in surgical menopause if one is still getting periods. Menopause symptoms often appear shortly after undergoing surgical menopause. Hormone treatment used briefly can help one feel better from problems genuinely bothering the patient.
Germany has one of the world's biggest medical technology industries and, by far, the largest industry in Europe. According to the Federal Ministry for Economic Affairs and Climate Action of Germany, the German medical device sector, which accounts for about USD 35.8 billion annually or 25.6% of the entire European market, is one of the most profitable healthcare industries in the world. Germany has a robust healthcare system, particularly regarding hospital beds, infrastructure, and skilled personnel. The healthcare industry's economic impact in Germany is EUR 678.2 billion (USD 798 billion), or around 12% of Germany's GDP. This will surge the market expansion of hysterectomy devices in Europe.
The Germany market dominated the Europe Hysterectomy Device Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $29.2 million by 2028. The UK market is anticipated to grow at a CAGR of 4.1% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 5.7% during (2022 - 2028).
Based on Disease Type, the market is segmented into Chronic Pelvic Pain, Fibroids, Uterine Cancer and Others. Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers and Others. Based on Surgical Approach, the market is segmented into Abdominal Hysterectomy, Laparoscopic Hysterectomy, Robotic-assisted Laparoscopic Hysterectomy and Vaginal Hysterectomy. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Worldwide Hysterectomy Device Market is Projected to reach USD 450.5 Million by 2028, at a CAGR of 5.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, B. Braun Melsungen AG, ConMed Corporation, Johnson & Johnson, Richard Wolf GmbH, Karl Storz SE & Co. KG, The Cooper Companies, Inc., Laborie Medical Technologies (Patricia Industries) (Investor AB), Fortimedix Surgical B.V., and Conkin Surgical Instruments Ltd.
By Disease Type
By End User
By Surgical Approach
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
